Jeffrey Marbach
University of Ottawa
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jeffrey Marbach.
Resuscitation | 2018
Juan Russo; Pietro Di Santo; Trevor Simard; Tyler E. James; Benjamin Hibbert; Etienne Couture; Jeffrey Marbach; Christina Osborne; F. Daniel Ramirez; George A. Wells; Marino Labinaz; Michel R. Le May
AIM OF THE STUDYnTo determine the optimal mean arterial pressure (MAP) during the early-to-intermediate phase care of comatose survivors of out-of-hospital cardiac arrest (OHCA).nnnMETHODSnWe identified consecutive comatose survivors of OHCA with an initial shockable rhythm. Using blood pressure-over-time plots, we calculated the area below pre-specified MAP thresholds (ABT; mmHg*hours) during the first 96u202fh of admission. We used incremental MAP thresholds ranging between 65 and 85u202fmmHg. Logistic regression analyses were used to examine the association between ABT and clinical outcomes for each MAP threshold and to adjust for age, duration of cardiac arrest, and bystander CPR. The primary outcome was severe neurological dysfunction as defined by a cerebral performance category (CPC) ≥3.nnnRESULTSnWe identified 122 consecutive OHCA patients meeting inclusion criteria. The rate of the primary outcome was 33%. There was a significant association between ABT and the rate of the primary outcome when MAP thresholds of 60 (pu202f=u202f0.01), 65 (pu202f<u202f0.01), 70 (pu202f<u202f0.01), 75 (pu202f<u202f0.01), and 80u202fmmHg (pu202f<u202f0.01) were used. This association was lost once a MAP threshold of 85u202fmmHg was reached (pu202f=u202f0.63). In the adjusted analysis, the association between ABT and the primary outcome was no longer present when the MAP threshold reached 75u202fmmHg.nnnCONCLUSIONSnIn comatose survivors of OHCA with an initial shockable rhythm, higher ABT is associated with increased rates of severe neurological dysfunction when MAP thresholds <75u202fmmHg are used. The current findings support the hypothesis that higher MAP targets (≥75u202fmmHg) may be indicated in this patient population.
Journal of the American College of Cardiology | 2017
Jeffrey Marbach; Michael S. Lauer; Robert Moreland; Trevor Simard; P. Kay Lund; Sherry Mills
Scholastic development of fellows-in-training (FIT) has been a recurrent theme in the Journal’s Fellows-in-Training & Early Career Page [(1,2)][1]. Although the importance of establishing mentorship and the benefits of peer collaboration have been emphasized, the role of the fellowship program as
Clinical and Investigative Medicine | 2017
Jeffrey Marbach; Joshua Feder; Altayyeb Yousef; F. Daniel Ramirez; Trevor Simard; Pietro DiSanto; Juan J. Russo; Paul Boland; Marino Labinaz; Christopher Glover; Alexander Dick; Benjamin Hibbert
PURPOSEnAcute kidney injury occurs in up to a quarter of patients following transcatheter aortic valve replacement (TAVR) and has been associated with increased short and long-term mortality rates. A variety of patient characteristics predictive of post-TAVR acute kidney injury (AKI) have been identified, however discrepancies among studies exist almost uniformly. We investigated the hypothesis that the change in glomerular filtration rate (ΔGFR) in response to contrast administered during pre-TAVR coronary angiography is predictive of ΔGFR post-TAVR.nnnMETHODSnThe study comprised 195 patients who underwent TAVR at a single center between August 2008 and June 2015 and were prospectively included in the CAPITAL TAVR registry. Multiple linear regression analysis was conducted to estimate the effect of independent variables on the change in renal function post-TAVR.nnnRESULTSnThere was no relationship identified between the ΔGFR post-angiogram and the ΔGFR post-TAVR (r=0.043, P=0.582). Multiple linear regression analysis revealed that a significant amount of the change in renal function post-TAVR can be explained by the patients baseline creatinine (beta coefficient, -0.310, P.
Catheterization and Cardiovascular Interventions | 2018
Jeffrey Marbach; Aws Almufleh; Jordan Bernick; Melissa Blondeau; Christina Osborne; Juan J. Russo; Benjamin Hibbert; Michael Froeschl; Marino Labinaz; Christopher Glover; Alexander Dick; Derek So; Aun-Yeong Chong; Michel R. Le May
We sought to describe the safety and efficacy outcomes of patients on warfarin presenting with ST‐elevation myocardial infarction (STEMI).
Canadian Journal of Cardiology | 2018
Jeffrey Marbach; Aws Almufleh; Michael Froeschl; Benjamin Hibbert
More than 3 decades ago, Wyngaarden and Gill first warned of the challenges facing physician-scientists in their seminal papers The Clinical Investigator as an Endangered Species and The End of the Physician-Scientist. In the years since these papers were published, there has been expansion of stage I-II preclinical research focusing on discovery and exploratory studies. Expansion has often come at the expense of physician-scientists whose traditional role has been to bridge the gap between early preclinical research (stage I-II) and clinical trials (stage IV). Consequently, a paradigm shift has occurred, and increasing pressure has been placed on physician-scientists to choose between clinical practice and fundamental research. This shift is particularly concerning in the field of cardiovascular medicine, where the ubiquitous nature and clinical significance of cardiovascular disease make the role of the translational scientist essential. The challenges facing academic cardiologists have then further been amplified by the necessity not only to maintain clinical competence but also to maintain competence in highly technical fields with rapidly advancing technology. Potential solutions to these problems include increasing support from postgraduate training programs, increased participation of trainees in physician-scientist development programs, and recognition of the pivotal role physician-scientists play in translational research by funding agencies. Although the physician-scientist remains an endangered species, multifaceted solutions with a focus on collaboration among institutions, training programs, and funding agencies have the potential to maximize efficiency in biomedical research and successfully translate scientific discoveries from bench to bedside.
American Journal of Medical Quality | 2018
Jeffrey Marbach; Drew Johnson; Juergen Kloo; Amit Vira; Scott W. Keith; Walter K. Kraft; Natalie Margules; David J. Whellan
Hospital discharge is a high-risk time period, and acute myocardial infarction (AMI) patients often have early readmissions. The authors hypothesized that a multifaceted AMI care coordination program would reduce early hospital readmission rates. The outcomes of patients receiving care coordination (n = 304) were compared to patients receiving standard care (n = 192). Multivariable analyses of the outcomes were conducted by conditional logistic regression of propensity score matched sets. The primary outcome—hospital readmission within 30 days of discharge—occurred in 18% of standard care patients and 11.8% of care coordination patients. Patients receiving care coordination demonstrated a 48% reduction in odds of readmission within 30 days (odds ratio = 0.52; P = .04; 95% CI = 0.28-0.97). These results are the first to demonstrate that inclusion in an AMI-specific care coordination program is associated with a significantly lower risk of 30-day hospital readmission.
Clinical Case Reports | 2017
Jeffrey Marbach; Colin Yeo; Martin S. Green; Girish M. Nair
Inappropriate implantable cardiac defibrillator (ICD) shocks are associated with significant morbidity and have the potential to trigger ventricular arrhythmias, cardiac decompensation, and death. We present a case of multiple inappropriate ICD therapies in rapid succession due electromagnetic interference from a Dr‐Hos transcutaneous electric nerve stimulator machine, and subsequently from a faulty electrical outlet.
Journal of the American College of Cardiology | 2018
Trevor Simard; Richard G. Jung; Pietro Di Santo; Francisco Ramirez; Alisha Labinaz; Ian Pitcher; Pouya Motazedian; Rebecca Rochman; Robert Moreland; Jeffrey Marbach; Paul Boland; Kiran Sarathy; Saleh Alghofaili; Juan Russo; Etienne Couture; Alexander Dick; Michael Froeschl; Michel R. Le May; Benjamin Hibbert
Journal of the American College of Cardiology | 2018
Juan Russo; Natasha Aleksova; Ian Pitcher; Mohammad Ali Faraz; Etienne Couture; Simon Parlow; Sarah Visintini; Trevor Simard; Paul Boland; Pietro Di Santo; Jeffrey Marbach; Francisco Ramirez; Derek So; Marino Labinaz; Michel R. Le May; Benjamin Hibbert
Journal of the American College of Cardiology | 2018
Kiran Sarathy; Richard G. Jung; Alisha Labinaz; Rebecca Rochman; Ian Pitcher; Pouya Motazedian; Francisco Ramirez; Pietro Di Santo; Jeffrey Marbach; Paul Boland; Benjamin Hibbert; Trevor Simard; Saleh Alghofaili; Juan Russo; Etienne Couture; Chris N. Glover; Marino Labinaz